Guangzhou Wondfo Biotech C (300482.SZ) traded flat 0 % during a 24 hours period ending at 10:18 PM Central Europe on Monday 26th. One Guangzhou Wondfo Biotech C stock can currently be bought for about CNY 16.27 on popular exchanges. Current supply of Guangzhou Wondfo Biotech C stocks is 464.7 mn. Guangzhou Wondfo Biotech C has a current market capitalization of CNY 7.4 bn and approximately CNY 86.6 mn worth of Guangzhou Wondfo Biotech C was traded on exchanges in the last 24 hours. Since last month end, Guangzhou Wondfo Biotech C has traded -3.23 % down. Simple moving average of last 200 days is at CNY 17.06. The highest price of past 52 weeks was recorded at CNY 26.29 on 01/26/2026. 52 weeks low was at CNY 15.05 on 10/23/2026.
Summary of the latest news for Guangzhou Wondfo Biotech C
Guangzhou Wondfo Biotech Co. has reported a notable expansion in its clinical diagnostic portfolio, driven by advances in artificial‑intelligence–enhanced testing. The company’s strategy focuses on integrating machine‑learning algorithms into image‑analysis and pathology workflows, aligning with national initiatives that encourage AI‑assisted medical diagnostics. Recent disclosures indicate that Wondfo has secured a series of new contracts and is scaling up its production capacity to meet rising demand for high‑throughput testing solutions. The company’s leadership highlighted progress in regulatory approvals and the launch of new product lines that incorporate AI‑powered interpretation modules. Analysts note that this trajectory reflects broader market momentum for AI integration in diagnostics, positioning Wondfo as a key player in the evolving landscape of digital pathology and point‑of‑care testing.
Here is how related stocks have performed in the past 24 hours:
Fengzhushou (301382.SZ) traded flat 0 % and now trades at CNY 30.23. Fengzhushou has a market capitalisation of CNY 8.8 bn. FENGZHUSHOU CO LTD has announced that its procurement of computing‑power servers will not be subject to market price fluctuations, citing a fixed‑price agreement with suppliers. The company is advancing the project in staged deliveries and payments, ensuring controlled costs and stable supply chains. The firm has secured sizable contracts for both server purchases and service agreements, positioning computing power as a secondary growth driver alongside its core internet‑digital goods business. Analysts note that the expanding demand for AI and large‑scale model training supports a favorable outlook for the computing‑power sector, with FENGZHUSHOU aiming to capture this opportunity through coordinated supplier relationships and systematic rollout of its server solutions.
Rendong Lt (002647.SZ) traded flat 0 % and now trades at CNY 7.63. Current market capitalisation for Rendong Lt is CNY 8.8 bn. Current price/earnings ratio for Rendong Lt is 131.7.
Sinofibers L (300777.SZ) traded flat 0 % and now trades at CNY 19.54. Sinofibers L has a market capitalisation of CNY 8.9 bn. Current price/earnings ratio for Sinofibers L is 155.22.
Sichuan Furong (603327.SS) traded flat 0 % and now trades at CNY 7.99. Sichuan Furong has a market capitalisation of CNY 1.2 bn. Current price/earnings ratio for Sichuan Furong is 56.85.
361 Degrees (1361.HK) traded up 3.23 % and now trades at HKD 4.7. 361 Degrees has a market capitalisation of HKD 10.4 bn. Current price/earnings ratio for 361 Degrees is 6.45.
About Guangzhou Wondfo Biotech C
Guangzhou Wondfo Biotech Co.,Ltd is a biological company that manufactures and sells rapid diagnostic reagents and related equipment in China and internationally. The company offers rapid test kits for DOA, fertility, infectious and sexually transmitted diseases, tumor, coagulation, diabetes and rental injury, thyroid hormone, cardiovascular, and others; immune fluorescent tests systems; glucose monitoring systems; and raw materials. Guangzhou Wondfo Biotech Co.,Ltd was founded in 1992 and is headquartered in Guangzhou, China. The company’s website is www.wondfo.com.cn and it is listed on the Shenzhen Stock Exchange.